[Elsevier] [Supplementary]Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial

augustint Post time Half hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-09-25 03:48

Reward10points

Clinical Trial
Lancet Diabetes Endocrinol

. 2022 Mar;10(3):193-206.
doi: 10.1016/S2213-8587(22)00008-0. Epub 2022 Feb 4.
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trialTakashi Kadowaki 1, Joakim Isendahl 2, Usman Khalid 2, Sang Yeoup Lee 3, Tomoyuki Nishida 4, Wataru Ogawa 5, Kazuyuki Tobe 6, Toshimasa Yamauchi 7, Soo Lim 8; STEP 6 investigators

Reply